The effects of the lectins, wheat germ agglutinin (WGA) and concanavalin A (Con A) on endothelium intact pre-contracted rabbit aorta were investigated. WGA (8.3pM) produced endothelium-dependent relaxations, while Con A (4.3 pM) produced a partially endothelium-dependent relaxation. The endothelium-dependent relaxations to WGA were completely reversed by N-acetylglucosamine, haemoglobin and methylene blue and were partially reversed by NG-monomethyl-L-arginine (L-NMMA). It is suggested that WGA works as an agonist in releasing endothelium-derived relaxing factor (EDRF) from the endothelium of rabbit aorta by interacting with a glycosylated receptor on endothelial cells.
The recovery of functional cell-surface bFGF receptors after trypsin treatment was studied in BHK cells and NIH 3T3 cells. Restoration of functional bFGF receptors occurred at an approximately linear rate with 50% of the high-affinity binding capacity restored after 4 hr. Restoration of functional receptors required protein synthesis but not RNA synthesis. Upon exposure of BHK cells to bFGF, cell-surface receptors were rapidly lost, with only 25% remaining after 1 hr. When the bFGF was removed, down-regulated BHK and NIH 3T3 cells recovered cell-surface receptors at about the same rate observed in trypsin-treated cells. The recovery of receptors after down-regulation was inhibited by protein synthesis inhibitors. Addition of the protein synthesis inhibitor cycloheximide to unperturbed cultures of BHK or NIH 3T3 cells resulted in a time-dependent loss of cell-surface bFGF receptors, demonstrating that the receptors turn over constantly in the absence of ligand. These results suggest that bFGF receptors do not recycle and must be continuously synthesized.
1 The effect of wheat germ agglutinin (WGA), concanavalin A (Con A) and lentil lectin agglutinin (LCA) were investigated on pre-contracted canine coronary artery rings in vitro. 2 In endothelium-intact canine coronary artery, contracted with the thromboxane A2-analogue, U46619, WGA relaxed the tissue in a concentration-dependent manner, with an inhibitory concentration (ICm) of 112 ± 17 nM (n = 6). In the absence of an endothelium, WGA did not cause any relaxation of the tissue. 3 In endothelium-intact canine coronary artery, contracted with the thromboxane A2-analogue, U46619, LCA relaxed the tissue in a concentration-dependent manner, with an inhibitory concentration (ICso) of 423.1 ± 41 nM (n = 6). In the absence of an endothelium, LCA produced a 20.1 + 1.1% (n = 6) relaxation at the highest concentration tested (3 JAM).4 Concanavalin A (Con A) relaxed canine coronary artery in a partial endothelium-dependent manner with an IC50 of 104 ± 19 nM on endothelium-intact coronary artery and an ICs of 1.3 ± 0.3 JAM (n = 6) on endothelium-denuded tissues.5 The relaxation effects of WGA were attenuated by 1 mM N0-monomethyl L-arginine (L-NMMA) and completely inhibited by haemoglobin (3 JAM), methylene blue (10 JAM) and LY 83583 (30 JM). Ibuprofen had no effect on WGA-induced relaxation.6 The relaxant effects of WGA were reversed by addition of 20 mM N-acetyl-D-glucosamine (GlcNAc) and N-acetyl-D-galactosamine (GalNAc) but not by a-mannose, D-(+)-galactose, and P-lactose, whereas the endothelin-dependent relaxations to LCA and Con A were unaffected. 7 The endothelium-dependent relaxation induced by the lectins was unaffected by pretreatment of the tissue with 1 JAM atropine. 8 In the absence of extracellular calcium, WGA was also able to release EDRF suggesting that WGA acts through a second messenger system to release intracellular calcium. 9 We suggest that WGA acts as an agonist to release EDRF from endothelial cells possibly by binding to a sugar moiety, specific receptor or adhesion molecules on the endothelial cell surface.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.